| Items | Drug Registration information |
|---|---|
| ID | 1712 |
| No | 1712 |
| Brand Name | LUCIDASA |
| Ingredients | DASATINIB 50 MG |
| Dosage Form | TABLET |
| Primary Packaging | BOTTLE |
| Storage | |
| Shelf Life | 2 YEARS |
| Pack Size | BOX OF 60'S/BOTTLE |
| Dispensing Category | |
| ATC Classification | |
| Pharmaceutical Class | |
| Indications | FOR THE TREAMENT OF NEWLY DIAGNOSED ADULTS WITH PHILADELPHIA CHROMOSOME-POSITIVE CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE, ADULT WITH CHRONIC, ACCELERATED, OR LYMPHOID BLAST PHASE PH+CML WITH RESISTANCE OR INTOLERANCE TO PRIOR THERAPY INCLUDING IMATINIB, ADULT WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBASTIC LEUKEMIA WITH RESISTANCE OR INTOLERANCE TO PRIOR THERAPY, PEDIATRIC PATIENTS 1 YEAR OF AGE AND OLDER WITH PH+CML IN CHRONIC PHASE |
| Contraindications | |
| Side Effects | |
| Unit Price | |
| EDL | NULL |
| Description | WHITE TABLET |
| Note | |
| License Owner | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
| Manufacturer | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
| Country | LAOS |
| Import Registration No | |
| Import Registration Date | |
| Activity | CERTIFICATE RELEASED |
| Applied Date | |
| FDD Registration No | 02 L 1298/25 |
| FDD Registration Date | 25/02/2025 |
| Expiry Date | 24/02/2030 |